Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 3
2007 2
2008 1
2009 1
2012 2
2013 8
2014 6
2015 6
2016 4
2017 8
2018 10
2019 13
2020 15
2021 12
2022 11
2023 10
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma.
Penas-Prado M, Armstrong TS, Gilbert MR. Penas-Prado M, et al. Handb Clin Neurol. 2012;105:485-506. doi: 10.1016/B978-0-444-53502-3.00004-5. Handb Clin Neurol. 2012. PMID: 22230514 Review. No abstract available.
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.
Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA 3rd, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Mellinghoff IK, et al. Among authors: penas prado m. Clin Cancer Res. 2021 Aug 15;27(16):4491-4499. doi: 10.1158/1078-0432.CCR-21-0611. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078652 Free PMC article. Clinical Trial.
Updates on Management of Adult Medulloblastoma.
Majd N, Penas-Prado M. Majd N, et al. Among authors: penas prado m. Curr Treat Options Oncol. 2019 Jun 24;20(8):64. doi: 10.1007/s11864-019-0663-0. Curr Treat Options Oncol. 2019. PMID: 31236711 Review.
Recent Therapeutic Advances in Pituitary Carcinoma.
Robertson IJ, Gregory TA, Waguespack SG, Penas-Prado M, Majd NK. Robertson IJ, et al. Among authors: penas prado m. J Immunother Precis Oncol. 2022 Dec 13;6(2):74-83. doi: 10.36401/JIPO-22-25. eCollection 2023 May. J Immunother Precis Oncol. 2022. PMID: 37214211 Free PMC article. Review.
Clinical impact of molecular profiling in rare brain tumors.
Pratt D, Penas-Prado M, Gilbert MR. Pratt D, et al. Among authors: penas prado m. Curr Opin Neurol. 2023 Dec 1;36(6):579-586. doi: 10.1097/WCO.0000000000001211. Epub 2023 Oct 4. Curr Opin Neurol. 2023. PMID: 37973025 Review.
The Alliance AMBUSH Trial: Rationale and Design.
Mahajan A, Shih H, Penas-Prado M, Ligon K, Aldape K, Hu LS, Loughan AR, Basso MR, Leeper HE, Nahed BV, Stott SL, Geyer S, Giannini C, Galanis E. Mahajan A, et al. Among authors: penas prado m. Cancers (Basel). 2022 Jan 14;14(2):414. doi: 10.3390/cancers14020414. Cancers (Basel). 2022. PMID: 35053576 Free PMC article. Review.
Progress in rare central nervous system tumors.
Penas-Prado M, Armstrong TS, Gilbert MR. Penas-Prado M, et al. Curr Opin Neurol. 2019 Dec;32(6):895-906. doi: 10.1097/WCO.0000000000000755. Curr Opin Neurol. 2019. PMID: 31577601 Review.
Repurposing chemotherapy-induced peripheral neuropathy grading.
Velasco R, Argyriou AA, Cornblath DR, Bruna P, Alberti P, Rossi E, Merkies ISJ, Psimaras D, Briani C, Lalisang RI, Schenone A, Cavaletti G, Bruna J; CI‐PeriNomS Group. Velasco R, et al. Eur J Neurol. 2024 Dec;31(12):e16457. doi: 10.1111/ene.16457. Epub 2024 Sep 16. Eur J Neurol. 2024. PMID: 39282967 Free PMC article.
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
Price M, Neff C, Nagarajan N, Kruchko C, Waite KA, Cioffi G, Cordeiro BB, Willmarth N, Penas-Prado M, Gilbert MR, Armstrong TS, Barnholtz-Sloan JS, Ostrom QT. Price M, et al. Among authors: penas prado m. Neuro Oncol. 2024 May 6;26(Supplement_3):iii1-iii53. doi: 10.1093/neuonc/noae047. Neuro Oncol. 2024. PMID: 38709657
Barriers to accrual and enrollment in brain tumor trials.
Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van den Bent M, Weller M, Reardon DA, Wen PY. Lee EQ, et al. Among authors: penas prado m. Neuro Oncol. 2019 Sep 6;21(9):1100-1117. doi: 10.1093/neuonc/noz104. Neuro Oncol. 2019. PMID: 31175826 Free PMC article. Review.
102 results